RNA medicines for liver diseases
Ochre Bio is a biotechnology company developing RNA medicines for chronic liver diseases.
What they do:
Next-generation mRNA platform to solve cancer, COVID and climate.
Quick facts:
HQ: Boston, MA, United States
What they do:
Patient Intelligence Platform for Genetic Disease
Quick facts:
HQ: San Francisco, CA, United States
What they do:
Arpeggio Bio develops drugs targeting transcription factors using AI…
Quick facts:
HQ: Boulder, CO, United States
What they do:
Kernal is creating mRNA 2.0 therapies that work in specific cells
Quick facts:
HQ: Boston, MA, United States
What they do:
Discovering drugs that target the DNA regulome
Quick facts:
HQ: Seattle, WA, United States
What they do:
Utilizing monogenic disorders to inform and solve highly complex…
Quick facts:
HQ: Portland, OR, United States
RNA medicines for liver diseases
London, United Kingdom
50 employees, according to the company profile.
There are no funding rounds for Ochre Bio in our data.
Similar startups: Helix Nanotechnologies, Probably Genetic, and Arpeggio Bio.